Moreover, they also showed that inhibition CD90-mediated signaling pathway with a small-molecule agent OSU-CG5 significantly reduced the CD90+ cells in and subsequently repressed the liver cancer growth [138]. The gene discussed is THY1; the disease is liver cancer.